Document is current
Any future updates will be listed below
-
Authors
Qi, Wen http://orcid.org/0000-0002-0756-6010
Robert, Antoine
Singbo, Narcisse
Ratelle, Lucie
Fortin, Paul R. http://orcid.org/0000-0002-7278-2596
Bessette, Louis http://orcid.org/0000-0002-6834-2731
Brown, Jacques P. http://orcid.org/0000-0003-1910-788X
Michou, Laëtitia http://orcid.org/0000-0002-8364-4164
-
Funding
Funding for this research was provided by:
Fondation CHU de Québec (N/A)
Fonds de Recherche du Québec - Santé (Career award)
Canada Research Chairs (N/A)
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 25 July 2024
First Online: 6 August 2024
Declarations
:
: This study was approved by the <i>CHU de Québec-Université Laval</i> Ethics Committee (IRB number 2020–5081). Authorization from the Director of Professional Services of the <i>CHU de Québec-Université Laval</i> was obtained prior to reviewing the patients’ electronic medical record.
: Not applicable.
: Dr Louis Bessette has served on Speaker’s bureau from Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Lilly, Novartis, Sanofi, Sandoz, Fresenius Kabi, Teva; has served as consultant. Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Lilly, Novartis, Sanofi, Sandoz, Gilead, Fresenius Kabi, Teva; has received research support from Amgen, BMS, Janssen, UCB, AbbVie, Pfizer, Merck, Celgene, Sanofi, Lilly, Novartis, Gilead. Dr Jacques P Brown has received research support from Mereo BioPharma, Radius Health, and Servier; has served as a consultant for Amgen, Gilead, Paladin, Pfizer, Servier and Ultragenyx; and has served on speakers’ bureau for Amgen, all outside of the scope of this manuscript. Dr Paul R Fortin has served as consultant on Lupus Advisory Boards of AstraZeneca, GSK and AbbVie. Dr Laëtitia Michou has received honoraria for a conference from Roche, Janssen, Abbvie, Amgen; has served as consultant on Advisory Boards of Pfizer, Roche, Amgen. The other authors declare that they have no competing interests.
